These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22678371)

  • 1. Shire drops 'emergency' Fabry's disease drug.
    Fox JL
    Nat Biotechnol; 2012 Jun; 30(6):478. PubMed ID: 22678371
    [No Abstract]   [Full Text] [Related]  

  • 2. First treatment for Fabry's disease.
    FDA Consum; 2003; 37(4):4. PubMed ID: 12971327
    [No Abstract]   [Full Text] [Related]  

  • 3. Enzyme replacement in the treatment of Fabry's disease. Is there a point-of-no-return?
    del Toro N; Milán JA; Palma A
    Nephrol Dial Transplant; 2004 Apr; 19(4):1018. PubMed ID: 15031378
    [No Abstract]   [Full Text] [Related]  

  • 4. Fabrazyme--recombinant protein treatment for Fabry's disease.
    Barngrover D
    J Biotechnol; 2002 May; 95(3):280-2. PubMed ID: 12080957
    [No Abstract]   [Full Text] [Related]  

  • 5. Enzyme replacement therapy for Fabry's disease.
    Waldek S; Germain DP; Wanner C; Warnock DG
    Lancet; 2010 May; 375(9725):1523; author reply 1523-4. PubMed ID: 20435225
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzyme replacement therapy for Fabry's disease.
    Deegan P
    Lancet; 2010 May; 375(9725):1522-3; author reply 1523-4. PubMed ID: 20435224
    [No Abstract]   [Full Text] [Related]  

  • 7. Enzyme therapy for Fabry's disease: registered for success?
    Knebelmann B; Kurschat C; Thadhani R
    Lancet; 2009 Dec; 374(9706):1950-1. PubMed ID: 19959220
    [No Abstract]   [Full Text] [Related]  

  • 8. Agalsidase: a second look. With hindsight: full data challenge efficacy.
    Prescrire Int; 2003 Oct; 12(67):168-71. PubMed ID: 14619828
    [No Abstract]   [Full Text] [Related]  

  • 9. PR interval and the response to enzyme-replacement therapy for Fabry's disease.
    Waldek S
    N Engl J Med; 2003 Mar; 348(12):1186-7. PubMed ID: 12646684
    [No Abstract]   [Full Text] [Related]  

  • 10. Enzyme replacement in Anderson-Fabry disease.
    Bengtsson BA; Johansson JO; Hollak C; Linthorst G; FeldtRasmussen U
    Lancet; 2003 Jan; 361(9354):352. PubMed ID: 12559898
    [No Abstract]   [Full Text] [Related]  

  • 11. New products highlight ambiguity of orphan drug law.
    Reid B
    Nat Biotechnol; 2003 Jan; 21(1):6-7. PubMed ID: 12511896
    [No Abstract]   [Full Text] [Related]  

  • 12. Enzyme replacement therapy in Fabry's disease: recent advances and clinical applications.
    Mignani R; Cagnoli L
    J Nephrol; 2004; 17(3):354-63. PubMed ID: 15365954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in ECG abnormalities and improvement of regional left ventricular function in a patient with Fabry's disease during enzyme-replacement therapy.
    Prinz C; Farr M; Hering D; Horstkotte D; Faber L
    Clin Res Cardiol; 2010 Jan; 99(1):53-5. PubMed ID: 19774328
    [No Abstract]   [Full Text] [Related]  

  • 14. Enzyme replacement therapy in Anderson-Fabry's disease: beneficial clinical effect on vital organ function.
    De Schoenmakere G; Chauveau D; Grünfeld JP
    Nephrol Dial Transplant; 2003 Jan; 18(1):33-5. PubMed ID: 12480957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of replacement enzyme therapy on central nervous system manifestations in Fabry's disease].
    Besson G; Vadot W; Guellerin J
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S257-9. PubMed ID: 21211675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fabry's disease. An orphan disease that has found a solution: enzymatic replacement with alpha-galactosidase].
    Selgas R; García de Lorenzo A; Valdés F; Beck M
    Nefrologia; 2001; 21(5):443-7. PubMed ID: 11795012
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal histology before and after effective enzyme replacement therapy in a patient with classical Fabry's disease.
    Hirashio S; Taguchi T; Naito T; Maki K; Ogata S; Taniyama K; Taniguchi Y; Yorioka N
    Clin Nephrol; 2009 May; 71(5):550-6. PubMed ID: 19473616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac involvement in Fabry's disease.
    Nicholls K
    Heart Lung Circ; 2005; 14 Suppl 2():S18-20. PubMed ID: 16352280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New therapies for Fabry's disease.
    Gahl WA
    N Engl J Med; 2001 Jul; 345(1):55-7. PubMed ID: 11439950
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anderson-Fabry's disease: diagnostic problems, therapeutic relevance, and clinical experience in the treatment of the disease with enzyme replacement therapy in nephropathic patients].
    Cianciaruso B; Pisani A; Andreucci MV; Parente N; Andria G; Federico S; Sabbatini M; Sessa A
    G Ital Nefrol; 2003; 20(2):113-9. PubMed ID: 12746795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.